Newsletter | March 11, 2025

03.11.25 -- Oral Solid Dosage Formulation And Process Development: A Case Study

SPONSOR

Webinar: Embracing Today, Shaping Tomorrow: Driving Innovation in Decentralized Manufacturing

With over 75% of U.S. hospitals facing medication shortages, decentralized manufacturing offers a vital solution by bringing drug production closer to patients. This webinar explores how Germfree and On Demand Pharmaceuticals’ collaboration enables on-site, agile medicine production. Learn how localized manufacturing enhances supply reliability, regulatory compliance, and patient access through cutting-edge cleanroom and compounding technologies. Click here to learn more.

INDUSTRY INSIGHTS

Improving The Efficiency Of PFAS And Other High-Profile Analysis

Explore the advantages of Liquid Chromatography-Mass Spectrometry system monitoring software in PFAS analysis, including improvements in resource efficiency and operational performance.

Guide To PUPSIT And Annex 1 In Aseptic Processing

Pre-use, post-sterilization integrity testing (PUPSIT) ensures filters remain undamaged and effective during aseptic manufacturing. Learn how you can successfully perform PUPSIT with proven solutions.

Finding The Right Aseptic Processing Approach

How should you approach building your aseptic processing line? Gain insight into the advantages of using a modular, configurable technology rather than custom fill-finish solutions.

Development Of A Container Closure Integrity Test Method For Autoinjectors

Find out how a non-destructive method can be developed to test container closure integrity in autoinjectors equipped with an optically transparent window.

The Advantages Of Blow/Fill/Seal Processing For Vaccine Production

Multicomponent filling and sterilizing systems represent unique advantages for vaccine production. Discover how B/F/S systems can be adapted for production without incurring any product degradation.

Microglia: Where We Came From And Where We Are Now

Watch as an expert discusses the evolution of microglia research and the future of this field, including the innovative tools being developed to investigate the role of microglia in health and disease.

Bridging The Digitalization Gap In Pharma Manufacturing

A PDA survey reveals moderate digitalization in pharma, highlighting gaps in advanced integration. Read about a system that accelerates digital transformation with scalable solutions for Pharma 4.0.

Characterization Of Pharmaceutical Materials With Modulated DSC

Modulated DSC addresses challenges in pharmaceutical material characterization that enables precise analysis of glass and overlapping transitions to enhance insights beyond standard DSC.

Optimizing Pediatric Product Development For Commercialization Success

Ensuring medication adherence in pediatric patients presents challenges for pharmacotherapy. Examine various dosing solutions and learn how to streamline your pediatric development journey.

Increasing Bioavailability With Amorphous Solid Dosage Formulations

Uncover the challenges associated with pH-dependent solubility for oral tyrosine kinase inhibitor drugs and how leveraging ASD formulation can help create more effective, patient-friendly drug products.

Overcoming The Challenges In Fabs And Fc-Fusion Development Programs

See how an integrated drug substance and drug product CMC strategy, along with technical case studies from process and analytical development, provide insight into tailored product-specific solutions.

A Smarter Strategy For Optimizing Oncology Drug Products

Ensure downstream clinical success by exploring the benefits of evaluating targeted oncology molecules in healthy volunteers to apply an effective platform to accelerate drug product optimization.

Design Testing Strategies To Develop A Drug-Device Combination Product

Leveraging the expertise and experience of a trusted partner can reduce risk and accelerate the time to market for drug-device combination products by creating an optimal Validation Master Plan.

"Ultra High” Potency Development And Manufacture

A biotech with limited experience in the development and manufacture of high potency compounds sought to develop a process for producing a highly potent API used to treat an unmet oncology need.

FEATURED EDITORIAL

Oral Solid Dosage Formulation And Process Development

Discover a drug substance that is currently in the preclinical phase and has shown promising results in selected animal models. The discussion topics include API physical chemical characteristics, technologies, formulation assessments, and more.

SOLUTIONS

State-Of-The-Art 3D Modeling Of Facilities And Systems

Small Molecule APIs: From Pre-RSM To Final API

The Future Of Glass Packaging Is Here

Panel And Ceiling Systems For Biosafety Laboratories

Link Your Antibody To Its Fullest Potential

Connect With Pharmaceutical Online: